Living Platform Ltd
Living Platform Ltd provides healthcare services and equipment, primarily generating revenue through its operations in the healthcare facilities and services sector.
Business. Living Platform Ltd (7091.T) is a healthcare services and equipment company primarily engaged in biotechnology activities within the healthcare facilities and services industry. The firm is headquartered in Japan and is listed on the Tokyo Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Living Platform Ltd (7091.T) is a healthcare services and equipment company primarily engaged in biotechnology activities within the healthcare facilities and services industry. The firm is headquartered in Japan and is listed on the Tokyo Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Living Platform Ltd has a liquidity position that is characterized by a current ratio of 1.08, indicating that the company has just enough current assets to cover its current liabilities. The company's price-to-book ratio is 3.17, and its price-to-tangible-book ratio is also 3.17, suggesting that the market is valuing the company's equity at a premium relative to its book value. The company's debt-to-equity ratio is 3.6, which is relatively high and indicates a significant reliance on debt financing.
In terms of profitability, Living Platform Ltd has a return on equity of 6.3%, which is a measure of how effectively the company is using shareholders' equity to generate profits. The return on assets is 0.94%, which is relatively low and suggests that the company is not efficiently using its assets to generate earnings. These metrics are compared against the industry's preferred metrics, and the company's performance appears to be below the median for its industry.
The company's revenue is concentrated in a single segment, as there are no disclosed segments beyond the overall healthcare facilities and services operations. Geographically, the company's exposure is primarily within Japan, as the financial data is reported in Japanese Yen and there is no indication of significant international operations.
Looking at the growth trajectory, the company's revenue for the latest period is reported at 4,369,434,000 JPY. The analyst estimates for the last actual revenue were 19,204,570,000 JPY, which suggests a significant discrepancy between the reported revenue and the analyst estimates. This discrepancy may indicate either a change in the company's operations or a potential issue with the accuracy of the financial reporting.
The risk assessment for Living Platform Ltd indicates a medium level of liquidity risk, with a key flag noting that the company's net cash is negative after subtracting total debt. The dilution risk is assessed as low, which suggests that the company is not expected to issue additional shares that could dilute existing shareholders' equity in the near term. The company's capital structure, with a high debt-to-equity ratio, may also contribute to credit risk, as the company's ability to meet its debt obligations could be affected by changes in interest rates or economic conditions.
Recent events related to Living Platform Ltd include the latest financial reporting, which shows a net income of 104,666,000 JPY. The company's operating cash flow is positive at 1,509,635,000 JPY, which is a positive sign for its ability to generate cash from operations. However, the capital expenditure is reported as a negative value of -631,301,000 JPY, which may indicate that the company is investing in new projects or assets. These recent financial activities suggest that the company is actively managing its operations and investments.
- Living Platform Ltd has a high debt-to-equity ratio of 3.6, indicating a significant reliance on debt financing.
- The company's return on equity is 6.3%, which is a measure of how effectively the company is using shareholders' equity to generate profits.
- The company's liquidity position is characterized by a current ratio of 1.08, indicating that the company has just enough current assets to cover its current liabilities.
- The company's price-to-book ratio is 3.17, suggesting that the market is valuing the company's equity at a premium relative to its book value.
- The company's net income is 104,666,000 JPY, and its operating cash flow is positive at 1,509,635,000 JPY, indicating a positive cash flow from operations.
- The company's capital expenditure is reported as a negative value of -631,301,000 JPY, which may indicate that the company is investing in new projects or assets.
Bull / Bear case
Generated · model-assistedRevenue grew 20.4% annually over four years, demonstrating strong top-line expansion momentum for the company.
Net income surged 93.1% year-over-year in fiscal 2025, indicating a significant acceleration in profitability.
Free cash flow turned positive in fiscal 2025, marking a critical shift from previous years of negative cash generation.
Cash conversion ratio of 14.42 is best-in-class compared to the cohort median of 1.36, highlighting operational strength.
Debt-to-equity ratio of 3.6 is significantly higher than the cohort median of 0.32, indicating excessive financial leverage.
The company faces high credit risk, suggesting potential difficulties in meeting financial obligations or securing favorable financing.
Medium liquidity risk flags potential challenges in meeting short-term financial obligations without significant asset liquidation.
In focus — financials by report
Revenue ¥5.63B, +14,5% YoY; Operating income +37,9% YoY.
- ▍Revenue ¥5.63B, +14,5% YoY
- ▍Operating income +37,9% YoY
- ▍Net income +69,7% YoY
- ▍Net margin 1.7%
Revenue ¥5.43B, +15,1% YoY; Operating income +149,7% YoY.
- ▍Revenue ¥5.43B, +15,1% YoY
- ▍Operating income +149,7% YoY
- ▍Net income +61,4% YoY
- ▍Net margin 1.7%
Revenue ¥5.35B, +17,3% YoY; Operating income +177,1% YoY.
- ▍Revenue ¥5.35B, +17,3% YoY
- ▍Operating income +177,1% YoY
- ▍Net income +90,0% YoY
- ▍Net margin 1.7%
Revenue ¥5.01B, +14,6% YoY; Operating income +119,0% YoY.
- ▍Revenue ¥5.01B, +14,6% YoY
- ▍Operating income +119,0% YoY
- ▍Net income +97,0% YoY
- ▍Net margin 4.1%
Revenue ¥4.91B; Operating income ¥109.9M.
- ▍Revenue ¥4.91B
- ▍Operating income ¥109.9M
- ▍Net margin 1.2%
Revenue ¥4.72B; Operating income ¥71.5M.
- ▍Revenue ¥4.72B
- ▍Operating income ¥71.5M
- ▍Net margin 1.2%
Revenue ¥4.56B; Operating income ¥42.0M.
- ▍Revenue ¥4.56B
- ▍Operating income ¥42.0M
- ▍Net margin 1.0%
Revenue ¥4.37B; Operating income ¥46.3M.
- ▍Revenue ¥4.37B
- ▍Operating income ¥46.3M
- ▍Net margin 2.4%
Revenue ¥19.20B, +15,2% YoY; Operating income +1 643,5% YoY.
- ▍Revenue ¥19.20B, +15,2% YoY
- ▍Operating income +1 643,5% YoY
- ▍Net income +93,1% YoY
- ▍Free cash flow +1 448,3% YoY
- ▍Net margin 1.9%
Revenue ¥16.66B, +21,7% YoY; Operating income +90,9% YoY.
- ▍Revenue ¥16.66B, +21,7% YoY
- ▍Operating income +90,9% YoY
- ▍Net income +106,5% YoY
- ▍Free cash flow +96,0% YoY
- ▍Net margin 1.1%
Revenue ¥13.69B, +17,8% YoY; Operating income −149,6% YoY.
- ▍Revenue ¥13.69B, +17,8% YoY
- ▍Operating income −149,6% YoY
- ▍Net income −77,5% YoY
- ▍Free cash flow +2,9% YoY
- ▍Net margin 0.7%
Revenue ¥11.63B, +27,3% YoY; Operating income +324,0% YoY.
- ▍Revenue ¥11.63B, +27,3% YoY
- ▍Operating income +324,0% YoY
- ▍Net income +617,0% YoY
- ▍Free cash flow +65,7% YoY
- ▍Net margin 3.5%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Living Platform Ltd Market data — financials · 2026-05-27
- Living Platform Ltd Market data — analyst estimates · 2026-05-27